Viridian Therapeutics, Inc. (FRA:1S1)
Germany · Delayed Price · Currency is EUR 26.49
-0.44 (-1.63%)
At close: Dec 19, 2025
Viridian Therapeutics Market Cap
Viridian Therapeutics has a market cap or net worth of €2.6 billion as of December 22, 2025. Its market cap has increased by 73.16% in one year.
Market Cap
2.60B
Enterprise Value
2.36B
Revenue
60.33M
Ranking
n/a
PE Ratio
n/a
Stock Price
€26.49
Market Cap Chart
Since February 14, 2017, Viridian Therapeutics's market cap has increased from 162.74M to 2.60B, an increase of 1,497.54%. That is a compound annual growth rate of 36.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 2.60B | 77.26% |
| Dec 31, 2024 | 1.47B | 41.55% |
| Dec 29, 2023 | 1.04B | -5.81% |
| Dec 30, 2022 | 1.10B | 191.32% |
| Dec 31, 2021 | 377.62M | 618.50% |
| Dec 31, 2020 | 52.56M | 286.62% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 243.93B |
| Siemens Aktiengesellschaft | 183.57B |
| Allianz SE | 146.73B |
| Deutsche Telekom AG | 130.04B |
| Siemens Energy AG | 102.30B |
| Rheinmetall AG | 71.12B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 70.51B |
| Deutsche Bank Aktiengesellschaft | 62.30B |